Louise von Stechow

Pharma and Biotech - Consultant / Communication Expert      


I am aiming to share my enthusiasm for the intersection of life sciences and technology, and help others to understand and communicate scientific matters.

Contributing Author   in
AI & Digital  

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Articles from Louise

From Diagnosis to Treatment: The Impact of AI on Rare Disease Drug Development

   1963
From Diagnosis to Treatment: The Impact of AI on Rare Disease Drug Development

Drug development for rare (also referred to as orphan) diseases is notoriously challenging. Legislative initiatives, such as the 1983 US Orphan Drug Act and 1999 EU Orphan Regulation, provide regulatory and economic incentives to drug developers. Despite an increase in the number of annually FDA-approved drugs with an orphan designation from 2 in 1983 to 33 in 2020, more than 90% of rare diseases still lack effective therapies.